Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Anthony

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Public Health Nursing (Boston, Mass.)|December 8, 2022
Building consensus in defining and conceptualizing acceptability of healthcare: A Delphi studyJoy Blaise Bucyibaruta, Mmapheko Doriccah, Lesley Bamford, et al.
Applied Clinical Informatics|March 24, 2022
Visualizing Opioid-Use Variation in a Pediatric Perioperative DashboardConrad W Safranek, Lauren Feitzinger, Alice Kate Cummings Joyner, et al.
Diseases of the Colon and Rectum|May 6, 2005
Practice parameters for the management of rectal cancer (revised)Joe J Tjandra, John W Kilkenny, W Donald Buie, et al.
Paediatric Anaesthesia|June 12, 2014
Continuous noninvasive cardiac output in children: is this the next generation of operating room monitors? Initial experience in 402 pediatric patientsCharles J Coté, Jinghu Sui, Thomas Anthony Anderson, et al.
Diseases of the Colon and Rectum|October 16, 2004
Practice parameters for colon cancerDaniel Otchy, Neil H Hyman, Clifford Simmang, et al.
Diseases of the Colon and Rectum|April 27, 2004
Practice parameters for the surveillance and follow-up of patients with colon and rectal cancerThomas Anthony, Clifford Simmang, Neil Hyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, et al.
Molecular Cancer Therapeutics|October 11, 2018
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor ImmunityTim H Holmström, Anu-Maarit Moilanen, Tarja Ikonen, et al.
Cell|August 14, 2024
Schwann cell-secreted PGE<sub>2</sub> promotes sensory neuron excitability during developmentHusniye Kantarci, Pablo D Elvira, Arun P Thottumkara, et al.
Science (New York, N.Y.)|December 1, 2022
Mastering the game of Stratego with model-free multiagent reinforcement learningJulien Perolat, Bart De Vylder, Daniel Hennes, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Public Health Nursing (Boston, Mass.)|December 8, 2022
Building consensus in defining and conceptualizing acceptability of healthcare: A Delphi studyJoy Blaise Bucyibaruta, Mmapheko Doriccah, Lesley Bamford, et al.
Applied Clinical Informatics|March 24, 2022
Visualizing Opioid-Use Variation in a Pediatric Perioperative DashboardConrad W Safranek, Lauren Feitzinger, Alice Kate Cummings Joyner, et al.
Diseases of the Colon and Rectum|May 6, 2005
Practice parameters for the management of rectal cancer (revised)Joe J Tjandra, John W Kilkenny, W Donald Buie, et al.
Paediatric Anaesthesia|June 12, 2014
Continuous noninvasive cardiac output in children: is this the next generation of operating room monitors? Initial experience in 402 pediatric patientsCharles J Coté, Jinghu Sui, Thomas Anthony Anderson, et al.
Diseases of the Colon and Rectum|October 16, 2004
Practice parameters for colon cancerDaniel Otchy, Neil H Hyman, Clifford Simmang, et al.
Diseases of the Colon and Rectum|April 27, 2004
Practice parameters for the surveillance and follow-up of patients with colon and rectal cancerThomas Anthony, Clifford Simmang, Neil Hyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, et al.
Molecular Cancer Therapeutics|October 11, 2018
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor ImmunityTim H Holmström, Anu-Maarit Moilanen, Tarja Ikonen, et al.
Cell|August 14, 2024
Schwann cell-secreted PGE<sub>2</sub> promotes sensory neuron excitability during developmentHusniye Kantarci, Pablo D Elvira, Arun P Thottumkara, et al.
Science (New York, N.Y.)|December 1, 2022
Mastering the game of Stratego with model-free multiagent reinforcement learningJulien Perolat, Bart De Vylder, Daniel Hennes, et al.
Pageof 13